Interest Expense in USD of Nascent Biotech Inc. from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Nascent Biotech Inc. quarterly/annual Interest Expense history and change rate from Q4 2013 to Q2 2024.
  • Nascent Biotech Inc. Interest Expense for the quarter ending 30 Jun 2024 was $1.95K, a 99.2% decline year-over-year.
  • Nascent Biotech Inc. Interest Expense for the twelve months ending 30 Jun 2024 was $149K, a 91.4% decline year-over-year.
  • Nascent Biotech Inc. annual Interest Expense for 2023 was $385K, a 75.4% decline from 2022.
  • Nascent Biotech Inc. annual Interest Expense for 2022 was $1.57M, a 3164% increase from 2021.
  • Nascent Biotech Inc. annual Interest Expense for 2021 was $48K, a 82.2% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $149K $1.95K -$236K -99.2% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $385K $22.3K -$550K -96.1% 01 Jan 2024 31 Mar 2024 10-K 01 Jul 2024
Q4 2023 $935K $107 -$649K -100% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2024
Q3 2023 $1.58M $125K -$151K -54.6% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $1.73M $238K +$168K +240% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 $1.57M $572K +$535K +1454% 01 Jan 2023 31 Mar 2023 10-K 01 Jul 2024
Q4 2022 $1.03M $649K +$644K +12772% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024
Q3 2022 $388K $276K +$273K +10390% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $114K $70K +$66.4K +1895% 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 $48K $36.8K -$30.6K -45.4% 01 Jan 2022 31 Mar 2022 10-K/A 03 Jul 2023
Q4 2021 $78.6K $5.04K -$49.9K -90.8% 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023
Q3 2021 $129K $2.63K -$56.1K -95.5% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $185K $3.51K -$84.7K -96% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $269K $67.5K -$12.9K -16.1% 01 Jan 2021 31 Mar 2021 10-K 15 Jun 2022
Q4 2020 $282K $55K +$53.1K +2764% 01 Oct 2020 31 Dec 2020 10-Q 14 Feb 2022
Q3 2020 $229K $58.8K +$54.4K +1257% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021
Q2 2020 $175K $88.2K +$88.2K 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $86.6K $80.4K 01 Jan 2020 31 Mar 2020 10-K 08 Jul 2021
Q4 2019 $1.92K 01 Oct 2019 31 Dec 2019 10-Q 09 Feb 2021
Q3 2019 $4.33K 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020
Q2 2019 $0 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q2 2016 $311K $54.1K +$30.3K +127% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017
Q1 2016 $280K $145K +$122K +537% 01 Jan 2016 31 Mar 2016 10-K 29 Jun 2017
Q4 2015 $158K $75.1K +$74.3K +9359% 01 Oct 2015 31 Dec 2015 10-Q 09 Feb 2017
Q3 2015 $83.8K $36.5K +$36.3K +21470% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $47.6K $23.8K +$23.6K +8924% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 $24K $22.8K 01 Jan 2015 31 Mar 2015 10-K 14 Jul 2016
Q4 2014 $794 -$3.19K -80.1% 01 Oct 2014 31 Dec 2014 10-Q 19 Feb 2016
Q3 2014 $169 01 Jul 2014 30 Sep 2014 10-Q 05 Nov 2015
Q2 2014 $264 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015
Q4 2013 $3.98K 01 Oct 2013 31 Dec 2013 10-Q 13 Feb 2015

Nascent Biotech Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $385K -$1.18M -75.4% 01 Apr 2023 31 Mar 2024 10-K 01 Jul 2024
2022 $1.57M +$1.52M +3164% 01 Apr 2022 31 Mar 2023 10-K 01 Jul 2024
2021 $48K -$221K -82.2% 01 Apr 2021 31 Mar 2022 10-K/A 03 Jul 2023
2020 $269K +$183K +211% 01 Apr 2020 31 Mar 2021 10-K 15 Jun 2022
2019 $86.6K +$86.6K 01 Apr 2019 31 Mar 2020 10-K 08 Jul 2021
2018 $0 01 Apr 2018 31 Mar 2019 10-K 22 Jun 2020
2016 $54.1K -$226K -80.7% 01 Apr 2016 31 Mar 2017 10-K 29 Jun 2018
2015 $280K +$256K +1069% 01 Apr 2015 31 Mar 2016 10-K 29 Jun 2017
2014 $24K +$12.1K +101% 01 Apr 2014 31 Mar 2015 10-K 14 Jul 2016
2013 $11.9K 01 Apr 2013 31 Mar 2014 10-K 02 Jul 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.